Volume 11, Number 6—June 2005
Dispatch
Community-associated Methicillin-resistant Staphylococcus aureus in Pediatric Patients
Theresa J. Ochoa*, John Mohr*, Audrey Wanger*†, James R. Murphy*, and Gloria P. Heresi*
Table 2
Site of infection with CA-MRSA or CA-MSSA*
| Site | No. MRSA (n = 159), (%) | No. MSSA (n = 80), (%) | p value |
|---|---|---|---|
| Abscess | 80 (50.3) | 23 (28.7) | <0.01 |
| Lymphadenitis | 35 (22.0) | 13 (16.2) | NS |
| Pneumonia | 17 (10.7) | 13 (16.2) | NS |
| Complicated pneumonia† | 12/17 (70.6) | 2/13 (15.4) | <0.01 |
| Cellulitis | 12 (7.5) | 8 (10.0) | NS |
| Osteoarticular‡ | 10 (6.3) | 8 (10.0) | NS |
| Other§ | 5 (3.1) | 15 (18.7) | ND |
*CA, community-associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus; NS, not significant; ND, not done (various diagnosis grouped).
†Empyema, necrotizing pneumonia, pneumatocele, or pneumothorax.
‡Osteomyelitis or septic arthritis.
§Sinusitis, preseptal and septal cellulitis, retropharyngeal and mediastinal abscess, urinary tract infection, toxic shock syndrome, isolated bacteremia.
